We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Swiss molecular diagnostics firm Novigenix announced Thursday that it purchased Diagnoplex’s Colox colorectal cancer test for an undisclosed sum. Read More